Franklin Resources’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,047
Closed -$112K 2868
2024
Q1
$112K Buy
+10,047
New +$141K ﹤0.01% 2697
2021
Q4
Sell
-229,505
Closed -$17M 2471
2021
Q3
$17M Hold
229,505
0.01% 929
2021
Q2
$12.5M Buy
229,505
+29,500
+15% +$1.77M ﹤0.01% 969
2021
Q1
$14.7M Hold
200,005
0.01% 900
2020
Q4
$17.2M Buy
200,005
+5
+0% +$301 0.01% 850
2020
Q3
$7.55M Buy
+200,000
New +$7.86M ﹤0.01% 970

Other funds holding ALXO

Franklin Resources's ALXO Position: Q2 2024 in Review

Franklin Resources sold out of ALX Oncology (ALXO) in Q2 2024, closing a stake of 10,047 shares — an estimated $112K sold.

Franklin Resources first reported a position in ALXO in Q3 2020 and held it in 6 quarters. The position peaked at $17.2M in Q4 2020. 111 funds tracked by Wall St. Rank hold ALXO as of Q2 2024.

  • Franklin Resources reported no remaining ALX Oncology position as of Q2 2024 after selling out during the quarter.
  • Franklin Resources sold 10,047 ALX Oncology shares in Q2 2024, an estimated $112K.
  • Franklin Resources first reported a position in ALX Oncology in Q3 2020 and held it in 6 quarters.
  • Franklin Resources's ALX Oncology position peaked at $17.2M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2024.

Based on Franklin Resources's 13F filing for Q2 2024, filed 14 Aug 2024.